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Abstract
Objective—To determine the prevalence of obesity and cardiometabolic risk in US Hispanic/
Latino youth and examine whether there are disparities by sex in cardiometabolic risk factors.
Study design—SOL Youth is a population-based cross-sectional study of 1466 Hispanic/Latino 
youth (8-16 years old) who were recruited from four urban US communities (Bronx, NY; Chicago, 
IL, Miami, FL, and San Diego, CA) in 2012-2014. The majority of children were US-born (78%) 
and from low-income and immigrant families. Cardiometabolic risk factors were defined using 
national age- and sex-specific guidelines.
Results—The prevalence of obesity was 26.5%. The prevalence of class II-III obesity, diabetes 
and dyslipidemia was high (9.7%, 16.5%, and 23.3%, respectively). The prevalence of 
cardiometabolic risk factors increased with severity of obesity in both, boys and girls. Boys had a 
higher prevalence of diabetes and of elevated blood pressure than girls (20.9% vs. 11.8% and 8.5% 
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vs. 3.3%). In multivariable analyses, younger boys were more likely to have obesity class II-III 
than girls (OR = 3.59; 95% CI 1.44, 8.97). Boys were more likely to have prediabetes than girls 
(OR = 2.02; 95% CI 1.35, 3.02), and the association was stronger at older ages.
Conclusions—The prevalence of cardiometabolic risk factors was high in this sample of 
Hispanic youth. Boys had a more adverse cardiometabolic profile compared with girls that may 
put them at higher risk of diabetes and cardiovascular disease later in life. Reasons for this 
disparity and the long-term clinical implications remain to be elucidated.
Hispanic/Latino youth are a fast growing segment of the United States (US) population, and 
make up 22% of all children under the age of 18 in the US.(1) Data from NHANES indicate 
that Hispanic youth have high rates of obesity (2, 3), but less is known about the burden of 
cardiometabolic risk factors in Hispanic/Latino children. Obesity and diabetes are leading 
cardiovascular risk factors among Hispanic/Latino adults, raising concerns about whether an 
increased risk of these conditions is also manifested at younger ages. Furthermore, although 
studies in adults indicate that women are at higher risk of obesity than men, among 
Hispanic/Latino youth these sex differences appear to be reversed, with boys more likely to 
be obese than girls (3, 4). However, adult men were found to have a higher prevalence of 
diabetes and cardiovascular risk factors than women (5, 6). Recent studies also indicate that 
there are sex differences in cardiometabolic risk profiles, with boys being more likely to 
have impaired fasting glucose than girls, but girls being more insulin resistant (7).
It is now well accepted that the process leading to atherosclerosis and other chronic 
conditions starts during childhood (8-11). Therefore, describing the magnitude of these risk 
factors in youth is important for prioritizing prevention and public health efforts. This study 
expands the literature on the health status of Hispanic/Latino youth by reporting on the 
prevalence of obesity and cardiometabolic risk factors in a community-based sample of 
Hispanic/Latino youth living in four major US urban areas. Because previous reports suggest 
that there is a higher burden of cardiometabolic risk in Hispanic young men compared with 
women, this study examined sex differences in the prevalence of obesity and 
cardiometabolic risk factors.
METHODS
HCHS/SOL is a population-based cohort study of 16,415 Hispanic/Latino adults (ages 18-74 
years) who were selected using a two-stage probability sampling design from four US 
communities (Chicago, IL; Miami, FL; Bronx, NY; San Diego, CA). SOL Youth is an 
ancillary study to HCHS/SOL that enrolled a subset of the offspring of HCHS/SOL 
participants from the same four field centers. Between 2012 and 2014, 6,741 households 
were screened via a phone call using a standardized script; the screening identified 1,777 
eligible children between the ages of 8-16 years, of whom 1,466 were enrolled, achieving a 
participation rate of 82%. Of these 1,466 children, 156 were excluded because they did not 
have values for one or more cardiometabolic factors or key covariates, leaving a final 
analytical sample of 1,310 for the current study. Details about the methodology and 
protocols of HCHS/SOL and SOL Youth are published elsewhere (12, 13). The study was 
conducted with approval from the institutional review boards of each of the institutions 
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involved in the study. Written informed consent and assent were obtained from parent/
caregivers and their children, respectively.
Height (cm) was measured with a wall stadiometer (SECA 222, Germany) and weight (kg) 
was obtained with a digital scale (Tanita Body Composition Analyzer, TBF 300, Japan). 
CDC guidelines were used to classify children into categories of underweight/normal weight 
(BMI <85th percentile), overweight (BMI 85th to <95th percentile), or obese (BMI ≥95th 
percentile) (14). Obese children were further classified by the severity of obesity using 
recommended pediatric thresholds (4, 15). Class I obesity was defined as ≥95% of the 95th 
percentile to <120% of the 95th percentile, class II obesity as ≥120% of the 95th percentile 
to <140% of the 95th percentile or BMI ≥35 to <40 kg/m2, and class III obesity (≥140% of 
the 95th percentile OR BMI≥40 kg/m2). Class II and III were combined to achieve adequate 
sample size for analyses. Seated blood pressure was measured after 5 minutes of rest using 
an OMRON HEM −907XL sphygmomanometer. Three consecutive measures were obtained 
and the average of the last two measures was used in the analyses. Age-, sex-, and height- 
specific systolic and diastolic blood pressure (SBP and DBP) percentiles were derived 
according to established guidelines (16). Elevated blood pressure was defined as having 
systolic or diastolic blood pressure ≥90th percentile.
Fasting plasma glucose was measured using a hexokinase enzymatic method (Roche 
Diagnostics). Hemoglobin A1c (HbA1c) was measured from whole blood using a Tosoh G7 
Automated HPLC Analyzer (Tosoh Bioscience Inc, South San Francisco, CA 94080). Pre-
diabetes/diabetes was defined as having fasting glucose ≥100 mg/dL or HbA1c ≥5.7%, 
according to the American Diabetes Association guidelines (17).
Blood for lipid assays were obtained under fasting conditions. Total serum cholesterol (TC) 
was measured using a cholesterol oxidase enzymatic method (Roche Diagnostics, 
Indianapolis, IN 46250), serum triglycerides using a glycerol blanking enzymatic method 
(Roche Diagnostics, Indianapolis, IN 46250), and high-density lipoprotein cholesterol 
(HDL-c) with a direct magnesium/dextran sulfate method. Low-density lipoprotein 
cholesterol (LDL-c) was calculated using the Friedewald equation. Non-HDL cholesterol 
was calculated as the difference between total cholesterol (TC) and HDL-c. Cutoffs values 
for each lipid were chosen based on the Expert Panel on Integrated Guidelines for 
Cardiovascular Health and Risk Reduction in Children and Adolescents (18). In addition, a 
TG/HDL-c ratio ≥ 2.2 was used because this cutoff has been related to higher 
cardiometabolic risk in youth (19). Lastly, dyslipidemia was defined as having total 
cholesterol ≥200 mg/dL, LDL-c ≥130 mg/dL; triglycerides ≥100 mg/dL for 8-9 year-old and 
≥130 mg/dL for 10-16 year-old; or HDL-c <40 mg/dL.
An index of overall cardiometabolic risk was calculated by summing the presence of the 
following eight risk factors: obesity (BMI ≥95th percentile); SBP or DBP ≥90th percentile; 
fasting glucose ≥100 mg/dL; HbA1c ≥5.7%; total cholesterol ≥200 mg/dL; LDL-c ≥130 
mg/dL; triglycerides ≥100 mg/dL for 8-9 year-old and ≥130 mg/dL for 10-16 year-old; or 
HDL-c <40 mg/dL. We then categorized participants as having 0, 1-2, or ≥3 cardiovascular 
disease risk (CVD) risk factors.
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The pubertal development scale (PDS) consists of 5 questions for boys concerning changes 
in body hair, voice, skin, growth spurt, and facial hair, and for girls questions about body 
hair, breast change, skin change, growth spurt, and menarche (20, 21).
Children and their parents/caregivers reported their Hispanic/Latino background (Central 
American, Cuban, Dominican, Mexican, Puerto Rican, South American, and other/mixed), 
place of birth, date of birth and sex. Parents/caregivers reported their household income and 
their educational attainment.
Statistical analyses
We calculated the weighted proportion of participants who had cardiometabolic risk factors 
overall and by sex. Test for linear trend was assessed using logistic regression with the 
binary variable for the CVD risk factor as the dependent variable, and weight category as the 
independent variable. Multivariable logistic regression was used to assess the association of 
sex (boys versus girls) with the presence of cardiometabolic risk factors. Multinomial 
logistical regression was used for outcomes that were not binary (weight category and CVD 
risk factors). Models adjusted for age, nativity, household income, parental education, and 
field center. Model 2 adjusted for all variables included in Model 1, plus percentile BMI in 
analyses that did not include obesity as the outcome variable. Analyses were presented for 
the overall sample; stratified by age group and by weight category. Sensitivity analysis 
included adjusting the multivariable models for Tanner stage of development in the subset of 
participants who had this variable available (N=898). All analyses were conducted with 
Stata version 14.0 (StataCorp, College Station, Texas, USA) and accounted for the complex 
survey sampling design (by including stratification and cluster variables) and sampling 
weights.
RESULTS
The sample included 380 children living in the Bronx, 304 in Chicago, 245 in Miami, and 
381 in San Diego. About half of the children in the target population were boys (51.4%) and 
a little over half (52.7%) were between the ages of 8-12 years. The majority of children were 
born within the 50 US states (78%) and were of immigrant parents (86% born outside the 50 
US States); 49% of children were of Mexican background. The majority of children came 
from low income households; 53% of them reported a household income of ≤$20,000 and 
38% of their parents reported less than a high school education. Characteristics of the study 
target population are presented in Table I.
Prevalence of obesity and cardiometabolic risk factors
The overall prevalence of overweight and obesity was 19.9% and 26.5%, respectively. The 
prevalence of overweight did not vary significantly by sex, but boys had a slightly higher 
prevalence of obesity than girls (28.4% vs. 24.6%) (Table II). The overall prevalence of 
obesity class II/III was 9.7% (CI: 7.1%, 12.1%), with boys having a slightly higher 
prevalence than girls (10.2%, CI: 7.6, 13.6; and 9.2%, CI: 6.5-12.8, respectively). Overall, 
the prevalence rates of prediabetes and dyslipidemia were high (16.5%, and 19.9%, 
respectively) (Table II). Boys had a higher prevalence of pre-diabetes compared with girls 
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(20.9% vs. 11.8%, respectively). Boys had almost three times the prevalence of elevated 
blood pressure, compared with girls, but the confidence intervals overlapped. The prevalence 
of dyslipidemia and individual lipid factors were similar in both sexes. About a one-half of 
the target population did not have any cardiovascular risk factors (Table II), with more girls 
being free of cardiovascular disease risk factors.
Obesity and cardiovascular disease risk factors
As expected, there was an increasing linear trend in number of cardiovascular disease risk 
factors across categories of weight, for both boys and girls (Figure). Notably, the prevalence 
of pre-diabetes among children with obesity class II/III was high (26%, CI: 18.1, 35.7), 
particularly among boys (31.4%, CI: 20.3, 45.2). Furthermore, more than 50% of boys and 
girls with class II/III obesity had dyslipidemia.
Sex differences in obesity and cardiovascular disease risk factors
Overall, the odds of obesity were similar in boys and girls (OR=1.25; 95% CI 0.87, 1.80). 
However, among children 8-10 years old, there was a higher odds of obesity in boys 
compared with girls (OR=2.14; 95% CI 1.14, 4.02) that was not observed in other age 
groups. Furthermore, boys 8-10 were almost four times more likely to have class II/III 
obesity, compared with girls (Table III). Boys had twice the odds of having pre-diabetes 
compared with girls (OR=2.02; 95% CI 1.35, 3.02), and this association was stronger at 
older ages. Boys aged 13-14 had higher odds of dyslipidemia than girls, but this association 
was not present in other age groups. When looking at individual lipid factors, there were no 
sex differences, except for high TG/HDL ration among 13-14 year old boys. Regarding 
blood pressure, boys were almost three times more likely than girls to have elevated blood 
pressure, but due to the low prevalence we could not estimate whether this association was 
consistent across all age groups. This disparity was not statistically significant when 
examining systolic or diastolic blood pressure separately. Furthermore, the presence of 
elevated number of cardiovascular disease risk factors (≥ 3) was similar in boys and girls and 
consistent across age groups. However, boys were more likely than girls to have a moderate 
number of cardiovascular disease risk factors (1-2), and this association was stronger among 
13-14 year old boys.
Tanner stage was derived, using the Pubertal Development Scale, in 69% of the sample (N = 
898). Of these, 13.6% had a Tanner Stage I-II, 39.6% had a Tanner Stage III-IV, and 46.8% 
reached Tanner Stage V. A comparison between those with Tanner stage and those without 
showed that these groups were similar in sex and BMI percentile, but those missing pubertal 
development stage were younger than those with that information (mean age 10.9 vs. 12.3, 
respectively. The associations above remained after adjustment for reported pubertal 
development (Table V; available at www.jpeds.com). We also examined whether disparities 
in cardiometabolic risk factors by sex were consistent across weight categories (Table IV). 
Interestingly, higher odds of pre-diabetes and moderate number of cardiovascular disease 
risk factors (1-2) in boys were only observed among the normal weight category.
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DISCUSSION
In this community-based study of Hispanic/Latino youth we observed significant sex 
differences in the prevalence of cardiometabolic risk factors. Younger boys were more likely 
to be obese than girls, but this disparity was not evident at older ages. Younger boys were 
more likely to have more severe levels of obesity (obesity class II/III) than girls. Notably, the 
study found a high prevalence of prediabetes/diabetes, with boys almost twice as likely to 
have pre-diabetes/diabetes compared with girls, a difference even more pronounced at older 
ages.
The high prevalence of severe obesity (class II/III) in this sample is also noteworthy, as it 
approximates rates of severe obesity in young adults (23). Consistent with prior research, the 
prevalence of cardiometabolic risk factors was higher in obese youth than in normal weight 
youth (4, 24). Furthermore, there was a strong impact of class II/III obesity on pre-diabetes 
and dyslipidemia. The prevalence of pre-diabetes among youth with class II/III obesity 
approximated rates reported for young adults (25) and dyslipidemia was found on more than 
50% of class II/III obese youth. Taken together, these results highlight the need for screening 
and lifestyle modification interventions to promote cardiovascular health in Hispanic/Latino 
youth as recommended by the Integrated Guidelines for Cardiovascular Health (18). A 
strong focus on weight reduction and control is necessary to prevent the developing of 
cardiovascular disease later in life.
Sex disparities in cardiometabolic risk factors have been described by others (7, 24, 26, 27) 
although few studies include Hispanic/Latino children in adequate numbers to examine 
results by sex. A prospective study of cardiometabolic risk factors during adolescence 
showed an increased risk in males that was independent of adiposity (27). Another study, 
based on NHANES data suggested that the impact of obesity on cardiometabolic risk factors 
was stronger in boys compared with girls (4). A large study of Hispanic/Latino youth in 
California found that boys were more likely to have impaired fasting glucose, but girls were 
more insulin resistant (7). It’s interesting to note that the adverse cardiometabolic profile in 
boys was observed among boys in the normal weight range and not among those with 
overweight or obesity. The reasons behind this cardiometabolic disadvantage observed in 
boys are poorly understood. Hormonal differences have been postulated as possible 
explanations (4, 27), as have behavioral factors such as differences in physical activity and 
sedentary behavior, however, no definitive conclusions have been reached (28, 29). 
Differences in body distribution of excess adiposity could be another explanation, as there 
are studies that suggest that visceral adiposity is a stronger influence on cardiometabolic 
abnormalities (30, 31).
The interpretation of results of this study requires caution due to some important limitations. 
First, the study sample is not representative of the overall Hispanic/Latino youth population 
in the US, but only of the communities from which the study enrolled; although these four 
urban communities are among the 15 metropolitan areas with the largest concentration of 
Hispanic/Latinos (32). The sample size does not allow us to test differences by Hispanic/
Latino national background. However, the prevalence of cardiometabolic risk factors in 
youth of Mexican background and youth of other backgrounds, were similar (Table VI; 
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available at www.jpeds.com). In adults, the HCHS/SOL study has reported important 
differences in cardiovascular disease risk factors (33), including diabetes, by Hispanic 
national background, with adults of Puerto Rican and Mexican backgrounds showing higher 
burden of CVD than adults from South American background. Another limitation is that oral 
glucose tolerance test was not available in this study, resulting in an incomplete 
characterization of pre-diabetes status that cannot distinguish between impairment of insulin 
secretion or reductions in β-cell function. Prior studies of pre-diabetes in youth suggest that 
impairment in insulin secretion plays a greater role than insulin resistance in the progression 
to type 2 diabetes, and having a combined phenotype of impaired glucose and impaired 
glucose tolerance confers an even greater risk for type 2 diabetes (34, 35). Another 
limitation is our measure of pubertal status, which was based on self-report and not available 
in all subjects. Nevertheless, in a sensitivity analysis, our associations were confirmed. 
Moreover, youth with pubertal assessment were not significantly different than those 
missing it on key demographic variables. Finally, conducting many subgroup analyses could 
increase the false positive rates, but sex and age comparisons were hypothesized a priori 
when designing the study.
Future studies need to address the longitudinal patterns of cardiometabolic risk factors to 
guide the identification of those most at risk of progression to type 2 diabetes and subclinical 
cardiovascular disease.
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Figure. 
Cardiometabolic risk by weight category in the Study of Latino Youth (SOL Youth). A, A, 
All, B, boys only, C, girls only.
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Table 1
Distribution of study population characteristics. The Study of Latino Youth (SOL Youth)
Unweighted n (Weighted %)
Field Center
  Bronx 380 (36.6)
  Chicago 304 (14.2)
  Miami 245 (14.0)
  San Diego 381 (35.2)
Age group
  8-10 years old 417 (30.9)
  11-12 years old 314 (21.8)
  13-14 years old 339 (22.6)
  15-16 years old 240 (24.8)
Male 653 (51.4)
US-born (within 50 US states ) 1014 (78.2)
Hispanic/Latino background
  Mexican 586 (48.9)
  Dominican 148 (13.5)
  Central American 100 (6.3)
  Puerto Rican 119 (10.5)
  Cuban 95 (5.7)
  South American 60 (4.2)
  Mixed 113 (9.1)
  Other 22 (1.9)
US-born parents (within 50 US states ) 174 (13.9)
Parental educational attainment
  < High school 502 (38.0)
  High school 372 (29.5)
  >High school 436 (32.5)
Household income
  ≤$20,000 695 (53.0)
  $21,000-$40,000 423 (31.7)
  >$40,000 192 (15.3)
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Table 2
Prevalence of cardiometabolic risk factors by sex (N = 1310). The Study of Latino Youth (SOL Youth)
Overall (N=1,310) Boys (N=653) Girls (N=657)
Weighted %
(95% CI)
Weighted %
(95% CI)
Weighted %
(95% CI)
Normal weight (BMI <85th percentile) 53.6 (49.9, 57.3) 52.0 (46.3, 57.7) 55.3 (50.1, 60.3)
Overweight (BMI 85-94th percentile) 19.9 (17.1, 23.0) 19.6 (15.5, 24.5) 20.1 (16.5, 24.3)
Obesity (BMI ≥95th percentile) 26.5 (23.5, 29.7) 28.4 (24.1, 33.1) 24.6 (20.3, 29.4)
Obesity Class I (≥95th percentile to
<120% of the 95th percentile) 16.8 (14.4, 19.5) 18.1 (14.7, 22.1) 15.4 (12.0, 19.6)
Obesity Class II (≥120% to <140% of the
95th percentile, or BMI≥35 and BMI<40) 8.0 (6.2, 10.3) 8.8 (6.4, 12.0) 7.2 (4.7, 10.7)
Obesity Class III (≥140% of the 95th
percentile or BMI≥40) 1.7 (1.1, 2.6) 1.4 (0.7, 2.8) 2.0 (1.2, 3.4)
Prediabetes/Diabetes 16.5 (14.0, 19.3) 20.9 (16.9, 25.6) 11.8 (9.1, 15.2)
Dyslipidemia 23.3 (20.3, 26.6) 24.6 (20.4, 29.3) 22.0 (17.9, 26.8)
High TC (≥200mg/dl) 6.0 (4.6, 7.7) 6.2 (4.5, 8.6) 5.7 (3.7, 8.6)
High LDL (≥130mg/dl) 4.3 (3.1, 5.7) 4.0 (2.7, 6.0) 4.5 (2.9, 6.9)
High TG (≥130 mg/dL for 10-19 y and ≥100
mg/dL for 8-9 y) 12.2 (9.9, 14.9) 12.8 (9.7, 16.8) 11.5 (8.5, 15.4)
Low HDL (<40mg/dl) 11.1 (9.2, 13.4) 11.6 (9.0, 14.9) 10.5 (7.9, 14.0)
High TG/HDL ratio (≥2.2) 20.3 (17.4, 23.5) 21.8 (17.7, 26.4) 18.7 (15.0, 23.2)
High non-HDL (≥145 mg/dL) 7.4 (5.7, 9.5) 7.3 (5.4, 9.9) 7.5 (5.0, 10.9)
Elevated blood pressure 5.9 (4.4, 8.0) 8.5 (5.9, 12.0) 3.3 (1.7, 6.3)
High SBP (SBP ≥90th percentile) 4.1 (2.8, 6.0) 5.8 (3.7, 8.8) 2.4 (1.1, 5.4)
High DBP (DBP ≥90th percentile) 2.4 (1.5, 4.0) 3.4 (1.8, 6.1) 1.4 (0.6, 3.4)
CVD risk factors
0 52.9 (49.5, 56.4) 47.8 (42.5, 53.2) 58.3 (53.2, 63.3)
1-2 36.8 (33.6, 40.1) 41.5 (36.3, 46.8) 31.9 (27.8, 36.2)
≥3 10.3 (8.4, 12.6) 10.7 (8.3, 13.7) 9.8 (7.0, 13.6)
Prediabetes/Diabetes is defined as fasting glucose ≥100 mg/dL or HbA1c ≥5.7%. Dyslipidemia is defined as having total cholesterol ≥200 mg/dL, 
LDL-c ≥130 mg/dL, triglycerides ≥100 mg/dL for 8-9 year-olds and ≥130 mg/dL for 10-16 year-olds, or HDL-c <40 mg/dL. Elevated blood 
pressure is defined as SBP or DBP ≥90th percentile. CVD risk factors may range from 0-9 and are defined as the following: obesity; SBP or DBP 
≥90th percentile; fasting glucose ≥100 mg/dL; HbA1c ≥5.7%; total cholesterol ≥200 mg/dL; LDL-c ≥130 mg/dL; triglycerides ≥100 mg/dL for 8-9 
year-olds and ≥130 mg/dL for 10-16 year-olds; HDL-c <40 mg/dL.
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Table 4
Adjusted Odds Ratios for cardiometabolic risk factors in boys versus girls by weight categories. The Study of 
Latino Youth (SOL Youth)
Normal weight
(N=666)
Overweight
(N=276)
Class I Obesity
(N=236)
Class II/III Obesity
(N=132)
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Odds ratio
(95% CI)
Pre-diabetes/Diabetes 2.93
(1.65, 5.20)
1.73
(0.77, 3.93)
0.98
(0.42, 2.72)
2.17
(0.74, 6.42)
Dyslipidemia 1.10
(0.62, 1.94)
1.13
(0.54, 2.33)
1.09
(0.57, 2.09)
1.20
(0.47, 3.09)
High total cholesterol 0.64
(0.27, 1.54)
3.34
(0.96, 11.57)
0.65
(0.18, 2.30)
5.59
(0.49, 64.05)
High LDL 0.16
(0.05, 0.54)
3.04
(0.80, 11.52)
0.94
(0.30, 2.95)
6.01
(0.51, 71.34)
High triglycerides 1.37
(0.52, 3.62)
0.70
(0.26, 1.89)
1.02
(0.48, 2.17)
1.34
(0.48, 3.68)
Low HDL 1.14
(0.50, 2.58)
1.28
(0.57, 2.86)
1.22
(0.59, 2.49)
0.66
(0.26, 1.69)
High TG/HDL ratio 1.00
(0.51, 1.99)
0.90
(0.43, 1.89)
1.64
(0.83, 3.23)
0.89
(0.32, 2.48)
High non-HDL 0.21
(0.07, 0.63)
2.83
(0.88, 9.04)
0.56
(0.22, 1.44)
2.39
(0.59, 9.62)
CVD risk factors (≥3 vs. 0) 0.15
(0.02, 1.09)
7.19
(1.57, 32.91)
1.23
(0.34, 4.52)
3.98
(0.71, 22.29)
CVD risk factors (1-2 vs. 0) 2.26
(1.39, 3.67)
1.05
(0.55, 1.99)
1.97
(0.97, 4.02)
1.25
(0.47, 3.32)
All models are adjusted for age, nativity, household income, parental education, and field center
Prediabetes/Diabetes is defined as fasting glucose ≥100 mg/dL or HbA1c ≥5.7%. Dyslipidemia is defined as having total cholesterol ≥200 mg/dL, 
LDL-c ≥130 mg/dL, triglycerides ≥100 mg/dL for 8-9 year-olds and ≥130 mg/dL for 10-16 year-olds, or HDL-c <40 mg/dL. CVD risk factors may 
range from 0-8 and are defined as the following: SBP or DBP ≥90th percentile; fasting glucose ≥100 mg/dL; HbA1c ≥5.7%; total cholesterol ≥200 
mg/dL; LDL-c ≥130 mg/dL; triglycerides ≥100 mg/dL for 8-9 year-olds and ≥130 mg/dL for 10-16 year-olds; HDL-c <40 mg/dL.
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Table 6
Prevalence of cardiometabolic risk factors stratified by Mexican background
Overall (N=1,310) Mexican background(N=586)
Non-Mexican background
(N=724)
Weighted %
(95% CI)
Weighted %
(95% CI)
Weighted %
(95% CI)
Normal weight (BMI <85th percentile) 53.6 (49.9, 57.3) 54.4 (48.8, 59.8) 52.9 (48.2, 57.6)
Overweight (BMI 85-94th percentile) 19.9 (17.1, 23.0) 19.1 (15.5, 23.3) 20.6 (17.1, 24.5)
Obesity (BMI ≥95th percentile) 26.5 (23.5, 29.7) 26.6 (22.3, 31.3) 26.5 (22.5, 30.9)
Obesity Class I (≥95th percentile to
<120% of the 95th percentile) 16.8 (14.4, 19.5) 17.7 (14.2, 21.8) 16.1 (12.9, 19.8)
Obesity Class II (≥120% to <140% of the
95th percentile, or BMI≥35 and BMI<40) 8.0 (6.2, 10.3) 7.3 (4.7, 11.2) 8.6 (6.4, 11.5)
Obesity Class III (≥140% of the 95th
percentile or BMI≥40) 1.7 (1.1, 2.6) 1.5 (0.8, 2.9) 1.8 (1.0, 3.3)
Prediabetes/Diabetes 16.5 (14.0, 19.3) 15.8 (12.4, 20.0) 17.1 (13.7, 21.2)
Dyslipidemia 23.3 (20.3, 26.6) 24.0 (19.5, 29.2) 22.7 (19.0, 26.9)
High TC (≥200mg/dl) 6.0 (4.6, 7.7) 5.3 (3.5, 8.2) 6.5 (4.7, 8.8)
High LDL (≥130mg/dl) 4.3 (3.1, 5.7) 2.9 (1.6, 5.2) 5.4 (3.8, 7.6)
High TG (≥100 mg/dL for 8-9 year-olds and
≥130 mg/dL for 10-16 year-olds ) 12.2 (9.9, 14.9) 14.0 (10.5, 18.3) 10.6 (7.9, 14.1)
Low HDL (<40mg/dl) 11.1 (9.2, 13.4) 11.7 (8.7, 15.5) 10.6 (8.2, 13.6)
High TG/HDL ratio (≥2.2) 20.3 (17.4, 23.5) 22.4 (18.3, 27.2) 18.4 (14.7, 22.8)
High non-HDL (≥ 145 mg/dL) 7.4 (5.7, 9.5) 7.1 (4.9, 10.3) 7.6 (5.5, 10.5)
Elevated blood pressure 5.9 (4.4, 8.0) 6.7 (4.2, 10.5) 5.3 (3.5, 7.9)
High SBP (SBP ≥90th percentile) 4.1 (2.8, 6.0) 4.6 (2.6, 8.0) 3.8 (2.3, 6.2)
High DBP (DBP ≥90th percentile) 2.4 (1.5, 4.0) 2.6 (1.2, 5.6) 2.2 (1.1, 4.2)
CVD risk factors (omitting HOMA-IR)
  0 52.9 (49.5, 56.4) 53.0 (48.3, 57.7) 52.8 (48.0, 57.6)
  1-2 36.8 (33.6, 40.1) 36.8 (32.1, 41.8) 36.8 (32.5, 41.3)
 ≥3 10.3 (8.4, 12.6) 10.2 (7.3, 13.9) 10.4 (7.9, 13.5)
Prediabetes/Diabetes is defined as fasting glucose ≥100 mg/dL or HbA1c ≥5.7%. Dyslipidemia is defined as having total cholesterol ≥200 mg/dL, 
LDL-c ≥130 mg/dL, triglycerides ≥100 mg/dL for 8-9 year-olds and ≥130 mg/dL for 10-16 year-olds, or HDL-c <40 mg/dL. Elevated blood 
pressure is defined as SBP or DBP ≥90th percentile. CVD risk factors may range from 0-9 and are defined as the following: obesity; SBP or DBP 
≥90th percentile; fasting glucose ≥100 mg/dL; HbA1c ≥5.7%; total cholesterol ≥200 mg/dL; LDL-c ≥130 mg/dL; triglycerides ≥100 mg/dL for 8-9 
year-olds and ≥130 mg/dL for 10-16 year-olds; HDL-c <40 mg/dL.
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